|
EXAS
|
Exact Sciences Corporation
|
5.85%
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
4.25%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
4.15%
|
US
|
NASDAQ
|
|
MTD
|
Mettler-Toledo International, Inc.
|
3.79%
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
3.66%
|
US
|
NASDAQ
|
|
IQV
|
IQVIA Holdings, Inc.
|
3.55%
|
US
|
NYSE
|
|
CRL
|
Charles River Laboratories International, Inc.
|
3.52%
|
US
|
NYSE
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
3.51%
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
3.48%
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
3.44%
|
US
|
NYSE
|
|
ALKS
|
Alkermes plc
|
3.44%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
3.42%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
3.39%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
3.25%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
3.25%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
3.22%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
3.12%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
3.09%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
3.09%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
3.07%
|
US
|
NASDAQ
|